Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole vs Tamoxifen in Postmenopausal DCIS
NCT00053898Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- Jan 2003
- Primary completion
- Mar 2015
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of anastrozole in ductal carcinoma in situ (DCIS), sponsored by NSABP Foundation. Started Jan 2003; status: completed.
02
Drugs
anastrozole
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT00053898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053898.